SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
percutaneous coronary
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
60
1
current therapy of the right ventricle myocardial infarction
2
Intravascular ultrasound-guided percutaneous coronary intervention in left main coronary bifurcation lesions: a review
3
Impact of stent deployment pressure and poststenting dilatation on the outcome of elective percutaneous coronary intervention
4
Coronary arterial complications after percutaneous coronary intervention in Behçet’s disease
5
Intravascular ultrasound-guided percutaneous coronary intervention in left main coronary bifurcation lesions: a review
6
Impact of stent deployment pressure and poststenting dilatation on the outcome of elective percutaneous coronary intervention
7
Coronary arterial complications after percutaneous coronary intervention in Behçet’s disease
8
MRI discriminates thrombus composition and ST resolution after percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
9
Coronary Artery Bypass Graft Surgery Improves Survival Without Increasing the Risk of Stroke in Patients with Ischemic Heart Failure in Comparison to Percutaneous Coronary Intervention: A Meta-Analysis With 54,173 Patients.
10
Ultrasound-guided bilateral combined inguinal femoral and subgluteal sciatic nerve blocks for simultaneous bilateral below-knee amputations due to bilateral diabetic foot gangrene unresponsive to peripheral arterial angioplasty and bypass surgery in a coagulopathic patient on antiplatelet therapy with a history of percutaneous coronary intervention for ischemic heart disease: A case report
11
[Effect of ABO blood groups on long-term outcome of stable coronary artery disease after percutaneous coronary intervention].
12
Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention.
13
Potential of circulating pro-angiogenic microRNA expressions as biomarkers for rapid angiographic stenotic progression and restenosis risks in coronary artery disease patients underwent percutaneous coronary intervention.
14
Brief, one-on-one, telephone-adapted mindfulness-based stress reduction for patients undergoing percutaneous coronary intervention: a randomized controlled trial.
15
Prognostic Value of Coronary Microvascular Function Measured Immediately After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: An International Multicenter Study.
16
Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis.
17
Angiographic characteristics and in hospital outcome of young patients, age up to 40 versus more than 40 years undergoing primary percutaneous coronary intervention.
18
Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery.
19
Technical features local vascular complications and patient experiences regarding of vascular entry path used for percutaneous coronary intervention
20
Predicting Successful Guidewire Crossing via Collateral Channel at Retrograde Percutaneous Coronary Intervention for Chronic Total Occlusion: The J-Channel Score as a Difficulty Estimating Tool for Collateral Channel Guidewire Crossing Success from the Japanese CTO-PCI Expert Registry.
21
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels: A Multicenter Registry
22
Impact of coronary collaterals on outcome following percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)
23
Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
24
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
25
Impact of non-respect of SYNTAX score II recommendation for surgery in patients with left main coronary artery disease treated by percutaneous coronary intervention: an EXCEL substudy.
26
Quantitative Flow Ratio guided Residual Functional SYNTAX Score for Risk Assessment in Patients with ST-Segment Elevation Myocardial Infarction undergoing Percutaneous Coronary Intervention.
27
Value of Syntax Score II in Prediction of New-Onset Atrial Fibrillation in Patients With NSTE-ACS Undergoing Percutaneous Coronary Intervention
28
Effect of a nurse-led individualized self-management program for Chinese patients with acute myocardial infarction undergoing percutaneous coronary intervention.
29
Mitral annular calcification predicted major cardiovascular events in patients presented with acute coronary syndrome and underwent percutaneous coronary intervention.
30
Relation Between Operator and Hospital Volumes and Long-Term Outcomes for Percutaneous Coronary Intervention in New York.
31
Centers of Excellence Designations, Clinical Outcomes, and Characteristics of Hospitals Performing Percutaneous Coronary Interventions
32
Validation of Bleeding Risk Criteria (ARC-HBR) in Patients Undergoing Percutaneous Coronary Intervention and Comparison with Contemporary Bleeding Risk Scores.
33
temporal trends in prevalence and antithrombotic treatment among asians with atrial fibrillation undergoing percutaneous coronary intervention: a nationwide korean population-based study.
34
the relationship between vegfa and tgfb1 polymorphisms and target lesion revascularization after elective percutaneous coronary intervention
35
coronary plaque morphology on multi-modality imagining and periprocedural myocardial infarction after percutaneous coronary intervention
36
clinical therapeutic efficacy of intra-aortic balloon pump as an adjuvant treatment after percutaneous coronary intervention in patients with coronary heart disease associated with chronic kidney disease
37
safety and clinical-cost effectiveness of percutaneous coronary interventions with overnight hospitalization
38
evaluating the impact of fractional flow reserve-guided percutaneous coronary intervention in intermediate coronary artery lesions on the mode of treatment and their outcomes: an iranian experience
39
solid right ventricular compression by intraventricular septum-hematoma induced after percutaneous coronary intervention
40
simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
41
short-term cost-effectiveness of reteplase versus primary percutaneous coronary intervention in patients with acute stemi a tertiary hospital in iran
42
prognostic analysis for cardiogenic shock in patients with acute myocardial infarction receiving percutaneous coronary intervention
43
analysis of grade iii coronary perforations during percutaneous coronary interventions – are some coronary segments more vulnerable?
44
incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute st-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis
45
assessment of prognostic value of angiographic perfusion score following percutaneous coronary intervention in patients with acute coronary syndrome
46
importance of hospital entry: walk-in stemi and primary percutaneous coronary intervention
47
primary percutaneous coronary intervention in the isfahan province, iran; a situation analysis and needs assessment
48
administration of low molecular weight and unfractionated heparin during percutaneous coronary intervention
49
association between peak neutrophil count, clopidogrel loading dose, and left ventricular systolic function in patients with primary percutaneous coronary intervention
50
mycotic aneurysm of the left anterior descending coronary artery induced by ‘mother-and-child’ catheter assisted percutaneous coronary angioplasty!
51
fractional flow reserve-guided percutaneous coronary intervention: standing the test of time
52
triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
53
primary percutaneous coronary intervention in the presence of acute pancreatitis following rupture of wirsung duct
54
successful percutaneous coronary intervention after transcatheter aortic valve implantation with corevalve bioprosthesis
55
comparison of health-related quality of life after percutaneous coronary intervention and coronary artery bypass surgery
56
gender-related analysis of in-hospital treatment and mortality of myocardial infarction patients undergoing percutaneous coronary intervention
57
risk-stratified cardiovascular screening including angiographic and procedural outcomes of percutaneous coronary interventions in renal transplant candidates
58
the effect of percutaneous coronary revascularization on plasma n-terminal pro-b-type natriuretic peptide levels in stable coronary artery disease
59
P097 * Prognostic significance of high sensitivity C-reactive protein before and after percutaneous coronary intervention in patients with angina pectoris
60
Collaborative Couple-Based Management Using King's Theory Improves Health Behaviors After Percutaneous Coronary Intervention for Coronary Artery Disease: Randomized Controlled Trial.